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a b s t r a c t 
Pseudomonas aeruginosa PAO1 (tobramycin MIC = 0.064 μg/mL) was used to perform agar diffusion tests 
employing tobramycin-containing tablets. Bacterial growth and formation of inhibition zones were stud- 
ied by stereomicroscopy and by blotting with microscope slides and staining with methylene blue, Alcian 
blue and a fluorescent lectin for the P. aeruginosa PSL, which was studied by confocal laser scanning mi- 
croscopy. Diffusion of tobramycin from the deposit was modelled using a 3D geometric version of Fick’s 
second law of diffusion. The time-dependent gradual increase in the minimum biofilm eradication con- 
centration (MBEC) was studied using a Calgary Biofilm Device. The early inhibition zone was visible after 
5 h of incubation. The corresponding calculated tobramycin concentration at the border was 1.9 μg/mL, 
which increased to 3.2 μg/mL and 6.3 μg/mL after 7 h and 24 h, respectively. The inhibition zone in- 
creased to the stable final zone after 7 h of incubation. Bacterial growth and small aggregate formation 
(young biofilms) took place inside the inhibition zone until the small aggregates contained less than ca. 
64 cells and production of polysaccharide matrix including PSL had begun; thereafter, the small bacterial 
aggregates were killed by tobramycin. Bacteria at the border of the stable inhibition zone and beyond 
continued to grow to a mature biofilm and produced large amount of polysaccharide-containing matrix. 
Formation of the inhibition zone during agar diffusion antimicrobial susceptibility testing is due to a 
switch from a planktonic to biofilm mode of growth and gives clinically important information about the 
increased antimicrobial tolerance of biofilms. 
© 2019 The Author(s). Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
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Soon after antibiotics began to be used to treat infections, the
need to test the susceptibility of the offending bacterium to var-
ious antibiotics became urgent since the occurrence of resistant
mutants of otherwise susceptible species became a problem. The
agar diffusion method became the most popular and clinically used
method employing agar cups, disks or tablets as deposits [1–6] .
The method has been repeatedly standardised internationally [7] ,∗ Corresponding authors. 
E-mail addresses: hoiby@hoibyniels.dk , hoiby@dadlnet.dk (N. Høiby), 
tsams@dtu.dk (T. Sams). 
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0924-8579/© 2019 The Author(s). Published by Elsevier B.V. This is an open access article
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) y the Clinical and Laboratory Standards Institute (CLSI) in the USA
 http://www.clsi.org ) and the European Committee on Antimicro-
ial Susceptibility Testing (EUCAST) in Europe ( http://www.eucast.
rg ), and is regarded as a good method for categorising bacteria
s susceptible, intermediate-susceptible or resistant to the systemic
se of antibiotics in accordance with the harmonised breakpoints
8] . Diffusion of antibiotics from the deposit in a disk or tablet
akes place in water within a 1% agar plate and follows Fick’s sec-
nd law of diffusion. The size of the inhibition zone was shown
o be dependent not only on the minimum inhibitory concentra-
ion (MIC) of the bacterium but also on the lag phase, the gen-
ration time of the bacterial strain and its inoculum, the amount
f antibiotic in the tablet, and the diffusibility of the antibiotic
 http://www.eucast.org ). Formation of the inhibition zone is read-under the CC BY-NC-ND license. 
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sble after ≤5 h of incubation but increases marginally during the
ext few hours, after which it becomes stable and colonies at the
order and beyond the inhibition zone continue to grow overnight.
These characteristics of inhibition zone formation indicate that
t may be the transition from a planktonic mode of growth (the
noculum) to a biofilm mode of growth that is decisive for inhi-
ition zone formation. Therefore, the present study aimed to in-
estigate the influence of the transition from a planktonic to a
iofilm mode of growth on the formation of the inhibition zone
f P. aeruginosa around a tablet containing tobramycin. The phar-
acokinetic/pharmacodynamic (PK/PD) relationship of tobramycin 
s concentration-dependent killing [9] . 
. Materials and methods 
.1. Bacterial strain 
Pseudomonas aeruginosa PAO1 [10] was used for the experi-
ents. The planktonic MIC of tobramycin measured by Etest is
.064 μg/mL for PAO1. Inocula of 10 7 CFU/mL [7] or 10 8 CFU/mL
EUCAST) ( = 0.5 MacFarland standard) were used and the plates
ere inoculated by floating. The low inoculum gives a 2 mm larger
one of inhibition and a 1.5 h longer time to study the growth of
icrocolonies before the inhibition zone is formed. 
.2. Antimicrobial tablets and antimicrobial susceptibility agar 
edium 
Neo-Sensitabs (Rosco Diagnostica A/S, Tåstrup, Denmark)
9 mm diameter) with 40 μg of diffusible tobramycin/tablet
molecular weight 467.54 g/mol, formula C 18 H 37 N 5 O 9 ) were used.
t a temperature of 37 °C, the diffusion constant ( D ) for tobramycin
s ca. 3.84 · 10 –5 cm 2 /s = 1.38 mm 2 /h [11] . ig. 1. Minimum biofilm eradication concentration (MBEC) determined using the Calgary
tart of biofilm growth of Pseudomonas aeruginosa PAO1 [13] . MIC, minimum inhibitory coCation-adjusted horse blood agar susceptibility medium (SSI Di-
gnostica, Hillerød, Denmark) was used. For some experiments,
here visualisation of bacterial growth was required on transpar-
nt agar, Luria–Bertani agar plates were used (SSI Diagnostica).
noculation, incubation and reading of the plates as well as stere-
microscopy was performed by two authors (NH and URJ) in an in-
ubation cabinet at 37 °C using an Olympus SZ61 stereomicroscope
Olympus, Tokyo, Japan). Microscopic examination of stained slides
as performed with an Olympus BX50 light microscope (Olym-
us). Confocal laser scanning microscopy was performed with a
eiss LSM510 confocal laser scanning microscope (Carl Zeiss, Jena,
ermany). 
The gradual increase in the minimum biofilm eradication con-
entration (MBEC) of tobramycin by increasing age of the biofilm
as determined in microtitre plates (Nunc A/S, Roskilde, Denmark)
sing the Calgary Biofilm Device method ( Fig. 1 ; Supplementary
ig. S1) with an inoculum of 10 7 CFU/mL [12] as described previ-
usly [13] . 
.3. Stains 
Methylene blue (Sigma-Aldrich Denmark A/S, Copenhagen, Den-
ark), Alcian blue (Sigma-Aldrich Denmark A/S) and PSL-specific
uorescein isothiocyanate-conjugated Hippeastrum hybrid lectin 
Amaryllis) (FITC-HHA lectin) (EY Laboratories, San Mateo, CA)
ere used [14] . 
.4. Calculation of the concentration of tobramycin in the agar plate 
Diffusion of antibiotic in the agar plate follows Fick’s second
aw of diffusion: 
∂c = D c  Biofilm Device [12] . The MBEC was determined at the specified time (h) after the 
ncentration. 
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Fig. 2. Concentration of tobramycin ( c tobra ) at radii ranging from 6.5 mm to 15 mm 
(lowest curve) as a function of time ( t ) in the full three-dimensional (3D) model in- 
cluding the effect of porosity of the Neo-Sensitabs ® tablet. The radius is taken from 
the centre of the tablet. The concentration at the top of the agar plate is plotted. 
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o  where c is the concentration of antibiotic, t is the time and D is
the diffusion constant for the antibiotic. This is valid when there
is no significant consumption of antibiotic and when the agar con-
centration is just a few percent [15] . We assume that there is no
significant adsorption of tobramycin to agar. 
2.5. Cylindrical geometry 
In the idealised situation where the antibiotic is added in a
small cylindrical hole in the middle of the agar plate, this produces
the Gaussian-shaped solution: 
c ( r, t ) = 1 
4 πDt 
exp 
(
−r 2 / 4 Dt 
)
Here we have normalised such that it integrates to 1 when in-
tegrated in the plane. If, instead, we wish to express the concen-
tration as mass/volume we get: 
c ( r, t ) = m 
h 0 
1 
4 πDt 
exp 
(
−r 2 / 4 Dt 
)
Here m is the mass of antibiotic added at the centre and h 0 is
the height of the agar. 
In practice, we do not start with a concentration in a narrow
cylinder at the centre. Rather, the antibiotic is added in a cylin-
der with finite radius r 0 . The antibiotic is therefore already spread
with the variance in a cylinder, σ 2 = 1 2 r 2 0 . The radial variance of
the Gaussian distribution is σ 2 = 4 Dt . The time required to build
up this variance is therefore: 
 0 = 
r 2 0 
8 D 
Including this advance spread we get the approximate solu-
tion: 
c ( r, t ) = m 
h 0 
1 
4 πD ( t + t 0 ) 
exp 
(
−r 2 / ( 4 D ( t + t 0 ) ) 
)
In Supplementary Fig. S2 we show a comparison between the
full calculation for selected radii and the shifted Gaussian version.
The specific calculation regarding the tobramycin-containing Neo-
Sensitabs ® tablet is performed with cylinder radius r 0 = 4.5 mm,
agar height h 0 = 6 mm and tobramycin mass m = 40 μg. The radius
of the small agar plate is R = 45 mm and the reflective boundary
does not influence the results in Fig. 2 and Supplementary Fig. S2.
For some experiments, larger agar plates were used with a radius
of 70 mm. 
2.6. Full three-dimensional (3D) geometry 
If the deposition of antibiotic is as a tablet on top of the agar,
we need to carry out a full 3D calculation. The Neo-Sensitabs ®
tablets are of radius r 0 = 4.5 mm and height h 0 = 1.55 mm. There-
fore, the thickness of the tablet cannot be assumed to be much
smaller than the height of the agar. The v/v concentration of wa-
ter in the tobramycin tablets may be estimated by weighing the
tablets before and after they are placed on the agar surface and
filled with water by capillary forces. The weight of the tablets in-
creases by 43 μg leading to a porosity (volume fraction occupied
by water) of ε = 0.436. The tortuosity of the porous channels will
be taken as τ = ε–1/2 from the Bruggeman model [16] . If we as-
sume that the porosity does not vary in time, the modified diffu-
sion equation reads: 
ε 
∂c 
∂t 
= ∇ ·
(
ε 
τ
D ∇c 
)
where c ( r, z, t ) is the concentration of antibiotic in the water seg-
ment. 
The diffusion equation is required to be continuous and respect
mass conservation across the boundary between the tablet and thegar. At all other boundaries, reflective boundary conditions are as-
umed. The initial concentration of tobramycin in the water frac-
ion of the tablet is c 0 = 930 μg/mL when we assume that the
obramycin is quickly going into solution. The numerical solution
f the diffusion equation is performed in COMSOL Multiphysics ®
.5.3.4 (Comsol AB, Stockholm, Sweden). 
. Results 
.1. Minimum biofilm eradication concentration 
Fig. 1 shows that the MBEC of P. aeruginosa PAO1 to tobramycin
ncreasing with time from 0.5 μg/mL (1 h) to 2–4 μg/mL after 4–6
 and 8–16 μg/mL after 10–24 h. 
.2. Calculated time-dependent concentration of tobramycin in the 
gar plate 
Comparison between the full 3D calculation, the 3D calculation
gnoring the porosity of the tablet, the full 2D calculation, and the
pproximate Gaussian solution described above is shown in Sup-
lementary Fig. S2. In the 3D calculation, we are displaying the
oncentration at the agar surface since this is where the bacteria
eside. It is seen that, particularly at early times compared with
he vertical equilibration time and small radii, it is of importance
o perform the full calculation. 
The concentration of tobramycin at radii ranging from 6.5 mm
o 15 mm (lowest curve) as a function of time in the full 3D model
ncluding the effect of porosity of the Neo-Sensitabs ® is shown in
ig. 2 . The concentration at the top of the agar plate is plotted.
or reference, the underlying calculated concentrations are listed
n Supplementary Table S1 as a function of time and radius. The
oncentration of the tobramycin profile in agar 7 h after placing
he Neo-Sensitabs ® tablet is shown in Fig. 3 . 
.3. Growth of Pseudomonas aeruginosa on blood agar plates during 
usceptibility testing with tobramycin disks 
By counting the bacterial cells on the agar surface using stere-
microscopy and by blotting the growth on the surface of the
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Fig. 3. Top: Illustration of the concentration of tobramycin profile in agar 7 h after placing the Neo-Sensitabs ® tablet. Bottom: Cross-section with indications of the 1 μg/mL 
and 5 μg/mL contours for the full calculation (yellow) and the shifted Gaussian (red). 
Table 1 
Correlation between the diameter of the inhibition zone of Pseudomonas aerugi- 
nosa PAO1 and the time (0–7 h) following inoculation of the agar plate (inoculum 
10 7 CFU/mL) when the tobramycin Neo-Sensitabs ® tablet was placed on surface of 
the agar and the diffusion began. The inhibition zone was read every 30 min. 
Tobramycin placed at: Inhibition zone (mm) read after incubation for: 
1–4 h 5 h 6 h 7 h 24 h 
0 h Invisible 22 23 24 24 < ∗
1 h Invisible 19 22 23 23 < 
2 h Invisible 18 19 19 19 < 
3 h Invisible 14 16 16 16 < 
4 h Invisible n.e.z. 14 15 15 < 
5 h Invisible n.e.z. n.e.z. 14 14 = ∗∗
6 h Invisible n.e.z. n.e.z. n.e.z. 15 
7 h Invisible n.e.z. n.e.z. n.e.z. 15 
n.e.z., no evaluable zone. 
∗ < the inhibition zone increased from barely visible to 24 h. 
= ∗∗ the inhibition zone was stable from barely visible to 24 h. 
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Fig. 4. Correlation between the diameter of the inhibition zone of Pseudomonas 
aeruginosa PAO1 and the time after seeding of the agar plate (inoculum 10 7 
CFU/mL) when the Neo-Sensitabs ® tobramycin tablet was placed on surface of the 
agar and the diffusion began. Top: time 0 h; clockwise, time 1, 2, 3, 4, 5 and 6 h; 
and centre, time 7 h. Plates were incubated for 24 h at 37 °C. 
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f  lood agar with a microscopy slide, fixing with methanol and
taining with methylene blue and studying the results with a light
icroscope, the lag phase of P. aeruginosa after seeding the blood
gar susceptibility medium was determined to be ca. 2 h. There-
fter, the doubling time became ca. 30 min during the 7 h of obser-
ation. Formation of an inhibition zone around the tobramycin disk
as visible both with the naked eye and with the stereomicro-
cope after 5 h with an inoculum of 10 7 CFU/mL ( Table 1 ), which
eans that the number of cells had increased by a factor ca. 2 8 ( =
56). The inhibition zone was already visible after 3.5 h when the
noculum was 10 8 CFU/mL. 
Fig. 4 and Table 1 show the observed inhibition zone diameter,
nd Table 2 , Fig. 2 and Supplementary Fig. S2 show the calculated
esults of the agar diffusion tests with tobramycin Neo-Sensitabs ®
dded at time 0–7 h after the inoculation and onset of the incu-
ation of the plates with P. aeruginosa PAO1 ( Fig. 4 ). As expected,
t is seen that the later the tobramycin tablets were placed on the
noculated agar surface, the smaller the inhibition zone became,
ndicating that the increasing amount of visible growth could not
e lysed by delayed placement of the tobramycin tablet on top of
he growth. 
The morphology of the bacterial growth inside and outside
he inhibition zone as visualised by stereomicroscopy is shown inig. 5 . The bacterial matrix is clearly seen at the border and outside
he border of the inhibition zone. 
Subculture guided by stereomicroscopy after 24 h of incubation
rom the area inside the inhibition zone even up to the border of
he zone and from the area where the early zone had been visible
fter 5 h of incubation failed to show any growth and the bac-
eria had therefore been killed by tobramycin ( Figs. 5–7 ). On the
ther hand, subculture from the border of the final zone always
howed growth, therefore the bacteria had survived tobramycin.
hese results were confirmed by propidium iodide staining in a
ew experiments (LIVE/DEAD ® Cell Viability Assay; Thermo Fisher
568 N. Høiby, K.- ˚A. Henneberg and H. Wang et al. / International Journal of Antimicrobial Agents 53 (2019) 564–573 
Table 2 
Calculated tobramycin concentration in agar at the border of the early (small) and the final (large) Pseudomonas aerug- 
inosa PAO1 inhibition zone after diffusion for n h (tobramycin MIC = 0.064 μg/mL). A Neo-Sensitabs ® tablet containing 
40 μg of diffusible tobramycin was placed on the inoculated agar (inoculum 10 7 CFU/mL) immediately (0 h) or after 1, 
2, 3, 4 or 5 h. Same experiment as in Table 1 . 
Tobramycin placed at: Diffusion time Tobramycin concentration (μg/mL) at the border of the inhibition zone 
Early inhibition zone after 5 h of 
incubation 
Final inhibition zone after 7 h of 
incubation 
22 mm diameter 24 mm diameter 
0 h 5 h 1.9 0.9 
7 h 3.2 1.8 
24 h 6.3 5.3 
19 mm diameter 23 mm diameter 
1 h 4 h 3.7 0.8 
6 h 5.9 1.9 
18 mm diameter 19 mm diameter 
2 h 3 h 3.5 2.3 
5 h 6.6 4.9 
14 mm diameter 16 mm diameter 
3 h 2 h 12.4 4.7 
4 h 18.2 10.1 
–a 15 mm diameter 
4 h 1 h – –
3 h – 11.5 
– 14 mm diameter 
5 h 0 h – –
2 h – 12.4 
MIC, minimum inhibitory concentration. 
a –, indicates no zone. 
Fig. 5. Stereomicroscopy photos of Pseudomonas aeruginosa PAO1 cells in the inhibition zone around a tobramycin Neo-Sensitabs ® tablet after 24 h of incubation. (A) The 
tobramycin tablet is seen at the left side and the border of the inhibition zone is indicated by two arrows. (B) Close up, the arrows are placed as in (A). The surface of the 
growth outside of the inhibition zone shows the presence of a self-produced matrix. (C) Morphology of the bacteria inside the inhibition zone. Scratches in the agar surface 
in (A) and (C) are artificial landmarks to facilitate microscopy. Magnification: (A) 40 ×; (B,C) 100 × . 
 
 
 
 
 
b  
a  
g  
a  
i  Scientific, USA) (data not shown). Bacterial growth at the border of
the inhibition zone had therefore obtained properties characteris-
tic of biofilm growth, which is observed in Fig. 7 C,E, and thereby
the growing biofilm aggregates had become more tolerant to to-
bramycin than the seeded planktonic bacteria. The size of the deadacterial aggregates inside the inhibition zones and the calculated
nd observed growth of the bacteria indicate that when the ag-
regates are less than ca. 64 cells (after 5 h of incubation with
 2-h lag phase; Fig. 8 B); they are later killed inside the early
nhibition zone by 3.2–6.3 μg/mL tobramycin ( Table 2 ; 7–24 h).
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Fig. 6. Growth of Pseudomonas aeruginosa PAO1 (inoculum 10 7 CFU/mL) seeded on the agar surface with a tobramycin Neo-Sensitabs ® tablet and incubated at 37 °C for 
24 h. The surface outside the area where the inhibition zone was expected was blotted with microscope slides, was fixed with methanol and was stained with methylene 
blue. 10 0 0 ×magnification. From top left, after the following incubation times: (A) 1 h; (B) 3 h; (C) 4 h; (D) 5 h; (E) 6 h; (F) 7 h; and (G) 24 h. 
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Fig. 7. Growth of Pseudomonas aeruginosa PAO1 (inoculum 10 7 CFU/mL) seeded on the agar surface with a tobramycin Neo-Sensitabs ® tablet and incubated at 37 °C for 24 h. 
The surface across the inhibition zone was blotted with microscope slides, was fixed with methanol and was stained with methylene blue. 10 0 0 ×magnification. (A,C) The 
border of the inhibition zone showing dense growth and a matrix between the bacterial cells. Bacterial aggregates inside the inhibition zone, also shown in (B) and (D), are 
dead as shown by stereomicroscopic-guided subculture. (E) Filamentous bacterial cells at the border of the inhibition zone probably due to the influence of tobramycin and 
the biofilm mode of growth. Bacteria inside the border of the inhibition zone are viable and showed dense growth following stereomicroscopic-guided subculture. 
N. Høiby, K.- ˚A. Henneberg and H. Wang et al. / International Journal of Antimicrobial Agents 53 (2019) 564–573 571 
Fig. 8. Growth of Pseudomonas aeruginosa PAO1 (inoculum 10 7 CFU/mL) seeded on the agar surface with a tobramycin Neo-Sensitabs ® tablet and incubated at 37 °C for 
24 h. The surface across the inhibition zone was blotted with microscope slides, was fixed with methanol and was stained with methylene blue. 10 0 0 ×magnification. (A–D) 
Polysaccharide production visualised by Alcian blue staining. Black arrow, surface rings of polysaccharide on the bacterial cells; orange arrow, extracellular polysaccharide. 
(A) The border of the inhibition zone (arrow). (B–D) The area just inside the border of the inhibition zone. (E,F) Confocal laser scanning microscopy of bacterial growth 
outside the inhibition zone, with P. aeruginosa PSL polysaccharide visualised by FITC-HHA lectin staining. Orange arrows, green fluorescence-stained PSL. FITC-HHA lectin, 
fluorescein isothiocyanate-conjugated Hippeastrum hybrid lectin (Amaryllis). 
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(  fter 7 h (the final inhibition zone), when the bacterial aggregates
each ca. 256 cells, then they remain tolerant against 1.8–5.3 μg/mL
obramycin ( Table 2 ; 7–24 h) and continue to grow in agreement
ith the biofilm results of the MBEC shown in Fig. 1 . The border
f the inhibition zone was sharply marked and the bacterial cells,
any with a filamentous shape, were separated by a self-produced
atrix, which is characteristic of biofilm growth ( Figs 5 B, 7 C,E). 
.4. Polysaccharides are present in the bacterial matrix of the 
seudomonas aeruginosa aggregates and biofilm growth 
Fig. 8 A shows that the matrix produced by bacterial growth
t the border and especially outside the border of the inhibition
one contains polysaccharide that is visualised by the Alcian blue
tain. It is seen in Fig. 8 C,D that both the outline or surface of the
acteria (visualised as a blue-stained ring outlining the bacterial
ell) and the extracellular matrix contain polysaccharide. At least
art of the polysaccharide is identified as PSL ( Fig. 8 E,F). Fig. 8 Bhows two polysaccharide-containing bacterial aggregates that 
ere located in the inhibition zone close to its border and that had
topped growing. Each of these aggregates contains ca. 64 cells, but
tereomicroscopy-guided subculture from such regions inside the
nhibition zone never showed growth, indicating that these small
ggregates had been killed by tobramycin. 
. Discussion 
Diffusion of tobramycin occurs in the water segment of the
edium used for antimicrobial susceptibility testing. Generally the
esults are therefore independent of the medium used. Bacteria
nd fungi occur as individual (planktonic) cells or clustered to-
ether in aggregates (biofilms) that may or may not adhere to
urfaces. Microbial biofilms are defined as structured consortia
aggregates) of microbial cells surrounded by a self-produced poly-
er matrix [17] . Biofilm-growing bacteria are much more tolerant
 = reversible resistance induced by the biofilm mode of growth,
572 N. Høiby, K.- ˚A. Henneberg and H. Wang et al. / International Journal of Antimicrobial Agents 53 (2019) 564–573 
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 in contrast to genetic resistance caused by mutations or horizon-
tal gene transfer) to antibiotics than planktonic bacteria [17–19] .
Colonies of bacteria growing on agar plates are surface-adhering
biofilms [20] and are therefore much more tolerant to antibiotics
than the inoculated planktonic bacterial inoculum used for deter-
mining antimicrobial susceptibility by the agar diffusion method.
In addition, the thicker the colony, the longer the diffusion time,
which scales as the square of the diffusion distance [21] . Despite
the much higher tolerance to antibiotics of biofilms measured by
MBEC (analogous to the planktonic minimum bactericidal concen-
tration), the PK/PD properties of antibiotics follow the same rules
for planktonic and biofilm-growing bacteria [13,22,23] . 
Generally, in vitro formation of bacterial biofilms on a surface
follows five steps: (i) reversible adhesion; (ii) irreversible adhesion;
(iii) bacteria divide to form aggregates and extracellular matrix is
produced, forming a young biofilm; (iv) the biofilm maturates and
becomes structured; and (v) dispersal of single cells and sludg-
ing off of biofilm aggregates [24] . The current results from the to-
bramycin agar diffusion assay agree with the first four steps. Plank-
tonic bacteria are seeded and start to grow and form aggregates,
and when the aggregates become greater than ca. 64 cells after 5
h of incubation they are more tolerant to tobramycin and continue
to grow and form a mature biofilm (256 cells) after 7h of incu-
bation, which is completely tolerant to tobramycin. These observa-
tions correlate well with previously published results [25] showing
in a surface-attached bacterial colony model that the bacterial cells
are entering tolerant, stationary growth after 6–7 h. The correlation
between the decreasing zone diameter and the delayed placing of
the tobramycin tablet after seeding is in accordance with the re-
sults reported by Nichols et al. [11] . The four steps of biofilm for-
mation also correlate with the gradual increasing MBEC. 
Calculation of the tobramycin concentration in the agar explains
the formation of the early and the stable inhibition zones, although
the growth conditions are different on agar plates and on pegs in
microtitre plates as also reported by Abbanat et al. [20] . 
Formation of the biofilm matrix (steps 3–4) was also shown
to occur in the experiments in the current study. Generally, the
biofilm matrix consists of polysaccharides, which is the most im-
portant component, proteins (e.g. pili, other adhesins, flagella) and
eDNA produced by the bacteria, and in vivo also of components
from the host [26,27] . We have now shown that the abundance
of matrix polysaccharide is produced by the non-mucoid P. aerug-
inosa PAO1 during the formation of aggregates and biofilm and
that the PSL polysaccharide is produced, which has been shown to
be important for biofilm formation in non-mucoid strains [14,28] .
Other polysaccharides that are stained by Alcian blue are, e.g.,
lipopolysaccharide as well as alginate [29] , which is produced in
small amounts by the non-mucoid PAO1 and is further induced
when a P. aeruginosa PAO1 biofilm is exposed to imipenem [30] .
Alginate is the dominating matrix polysaccharide in vitro and in
vivo in biofilms of mucoid phenotypes [30] . 
There is an important and clinically relevant interpretation of
the role of transition from planktonic growth to biofilm mode of
growth for the formation of the inhibition zone. Conventional in-
terpretation of the diameter of the inhibition zone is that the sus-
ceptible category based on clinical breakpoints [8] indicates that
it is probably successful to treat and eradicate infections caused
by planktonically-growing bacteria. However, the biofilm mode of
growth at the border of the inhibition zone and the correspond-
ing tobramycin concentration in the agar offers a new interpre-
tation, that the agar diffusion assay shows that it is probably not
successful to treat and eradicate biofilm infections caused by the
bacteria in question at least if a conventional dosing regimen is
used. This interpretation underlines that the conventional interpre-
tation of agar diffusion, like microtitre dilution assays, does not
provide key information to clinicians regarding the treatment ofiofilm infections [17] . In contrast to the microtitre dilution as-
ay, the agar diffusion assay gives visual information about the in-
reased antimicrobial tolerance of the biofilm mode of growth. The
algary Biofilm Device, which was used for determination of the
ime-dependent increase of tolerance to tobramycin, is designed
or measuring the MBEC of adhering biofilms and may be used for
hat purpose in the clinical microbiology laboratory [12,13,17] . 
In conclusion, formation of the inhibition zone during agar dif-
usion susceptibility testing is due to a switch from planktonically-
rowing bacteria to biofilm-growing bacteria with increased toler-
nce to antibiotics. The inhibition zone gives clinically important
nformation that biofilm-growing bacteria are tolerant to the dose
f antibiotic recommended for infections caused by planktonic-
rowing bacteria . Therefore, if treatment failure or recurrence oc-
urs, clinicians should suspect that the reason may be that biofilm-
rowing bacteria are causing the infection. 
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